ARCA Biopharma Inc ABIO:NASDAQ

Last Price$1.81Cboe Real-Time Last Sale as of 2:41PM ET 1/27/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.06(2.96%)
Bid (Size)$1.78 (500)
Ask (Size)$1.84 (600)
Day Low / High$1.80 - 1.97
Volume81.0 K

ARCA biopharma Enrolls First International Patient in Phase 2b Trial of rNAPc2 to Treat COVID-19

9:14AM ET 9/16/2021 MT Newswires
ARCA biopharma (ABIO) has enrolled the first international patient in a phase 2b clinical trial evaluating rNAPc2 as a potential treatment for patients hospitalized with COVID-19.

In addition to the patient, who was enrolled in Brazil, ARCA said it plans to enroll patients from Argentina and is currently enrolling patients at multiple sites in the US. Topline trial data is expected to be released in Q4.

Shares of ARCA biopharma are up nearly 1% in premarket trading. Topline trial data anticipated in the fourth quarter of 2021

Price: 3.1000, Change: +0.08, Percent Change: